Party Drug Ketamine (Special K) Likely To Become Anti-Depression Medicine

Mount Sinai Researchers Develop Machine Learning Model to Predict How CPAP Affects Cardiovascular Disease Risk in Patients With Obstructive Sleep Apnea

Mount Sinai Ophthalmologist Unveils Hospital’s First-in-Human Technology Enabling Real-Time Outflow Measurement During Eye Surgery

Icahn School of Medicine at Mount Sinai Awarded $8.2 Million NIH Grant to Investigate the Origins of Blood-Forming Stem Cells

Mount Sinai Performs First-in-the-World Liver Cancer Treatment Using More Flexible Scheduling Approach

Mount Sinai Study Finds Lung Cancer Surgery Safe for Many Patients Over 80

Researchers Identify Molecular “Brake” That Limits Axonal Regeneration After Injury to Nerves or Spinal Cord

Mount Sinai Enrolling Patients in DoD-Funded Clinical Trial of Drug-Free Neuromodulation Therapy for Postpartum Depression

Nearly 30 Percent of Patients With Resistant Hypertension Have a Hormone Disorder Caused by High Cortisol

Microaxial Flow Pump Does Not Improve Outcomes for High-Risk Heart Attack Patients Without Cardiogenic Shock

New Research Reveals Autism Risk Genes Are Shared Across Ancestries

Researchers Identify the Most Common Recessive Neurodevelopmental Disorder Ever Discovered